Bruce Eaton - 09 May 2022 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
EVP, CHIEF BUSINESS OFFICER
Signature
/s/ Bruce Eaton
Issuer symbol
EDIT
Transactions as of
09 May 2022
Net transactions value
-$3,895
Form type
4
Filing time
11 May 2022, 16:15:36 UTC
Previous filing
07 Mar 2022
Next filing
06 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Sale $3,895 -297 -0.44% $13.11 66,544 09 May 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on May 6, 2022. The sale does not represent a discretionary trade by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $12.8768 to $13.12. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.